Rescue Intravitreal Aflibercept Injection
VGFTe-AMD-1401
Approved small_molecule active
Quick answer
Rescue Intravitreal Aflibercept Injection for Neovascular Polypoidal Choroidal Vasculopathy is a Approved program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Neovascular Polypoidal Choroidal Vasculopathy
- Phase
- Approved
- Modality
- small_molecule
- Status
- active